Works matching IS 01615505 AND DT 2023 AND VI 64 AND IP 2

Results: 28

Michel Meignan, MD, PhD, 1947-2022.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 2, p. 342

By:

Barrington, Sally;
Buvat, Irèene;
Cottereau, Anne-Ségolène;
Gallamini, Andrea;
Thieblemont, Catherine

Publication type:

Article

Richard C. Reba, MD, 1932-2022.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 2, p. 342

By:

Barrington, Sally;
Buvat, Irèene;
Cottereau, Anne-Ségolène;
Gallamini, Andrea;
Thieblemont, Catherine

Publication type:

Article

Nuclear Medicine: The Essentials.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 2, p. 341, doi. 10.2967/jnumed.122.264788

By:

Alavi, Abass

Publication type:

Article

Dosimetry in Radiopharmaceutical Therapy.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 2, p. 339, doi. 10.2967/jnumed.122.265056

By:

Stabin, Michael

Publication type:

Article

Reply: Dosimetry in Radiopharmaceutical Therapy.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 2, p. 339, doi. 10.2967/jnumed.122.265078

By:

O'Donoghue, Joe;
Zanzonico, Pat;
Humm, John;
Kesner, Adam

Publication type:

Article

Precision of Myocardial Blood Flow and Flow Reserve Measurement During CZT SPECT Perfusion Imaging Processing: Intra- and Interobserver Variability.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 2, p. 260, doi. 10.2967/jnumed.122.264454

By:

Bailly, Matthieu;
Thibault, Frédérique;
Metrard, Gilles;
Courtehoux, Maxime;
Angoulvant, Denis;
Ribeiro, Maria Joao

Publication type:

Article

First-in-Humans PET/MRI of In Vivo GD2 Expression in Osteosarcoma.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 2, p. 337, doi. 10.2967/jnumed.122.264626

By:

Trautwein, Nils Florian;
Reischl, Gerald;
Seitz, Christian;
Dittmann, Helmut;
Seith, Ferdinand;
Scheuermann, Sophia;
Feuchtinger, Tobias;
Dombrowski, Frank;
Handgretinger, Rupert;
Fuchs, Jörg;
Pichler, Bernd;
la Fougère, Christian;
Schwenck, Johannes

Publication type:

Article

First-in-Humans Evaluation of Safety and Dosimetry of 64Cu-LLP2A for PET Imaging.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 2, p. 320, doi. 10.2967/jnumed.122.264349

By:

Laforest, Richard;
Ghai, Anchal;
Fraum, Tyler J.;
Reiko Oyama;
Frye, Jennifer;
Kaemmerer, Helen;
Gaehle, Greg;
Voller, Tom;
Mpoy, Cedric;
Rogers, Buck E.;
Fiala, Mark;
Shoghi, Kooresh I.;
Achilefu, Samuel;
Rettig, Michael;
Vij, Ravi;
DiPersio, John F.;
Schwarz, Sally;
Shokeen, Monica;
Dehdashti, Farrokh

Publication type:

Article

Fetal Dose from PET and CT in Pregnant Patients.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 2, p. 312, doi. 10.2967/jnumed.122.263959

By:

Burton, Christiane Sarah;
Frey, Kirk;
Fahey, Frederic;
Kaminski, Mark S.;
Brown, Richard K. J.;
Pohlen, Judith M.;
Shulkin, Barry L.

Publication type:

Article

Clinical Decision Support for Axillary Lymph Node Staging in Newly Diagnosed Breast Cancer Patients Based on 18F-FDG PET/MRI and Machine Learning.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 2, p. 304, doi. 10.2967/jnumed.122.264138

By:

Morawitz, Janna;
Sigl, Benjamin;
Rubbert, Christian;
Bruckmann, Nils-Martin;
Dietzel, Frederic;
Häberle, Lena J.;
Ting, Saskia;
Mohrmann, Svjetlana;
Ruckhäberle, Eugen;
Bittner, Ann-Kathrin;
Hoffmann, Oliver;
Baltzer, Pascal;
Kapetas, Panagiotis;
Helbich, Thomas;
Clauser, Paola;
Fendler, Wolfgang P.;
Rischpler, Christoph;
Herrmann, Ken;
Schaarschmidt, Benedikt M.;
Stang, Andreas

Publication type:

Article

Investigating Tau and Amyloid Tracer Skull Binding in Studies of Alzheimer Disease.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 2, p. 287, doi. 10.2967/jnumed.122.263948

By:

Flores, Shaney;
Chen, Charles D.;
Yi Su;
Dincer, Aylin;
Keefe, Sarah J.;
McKay, Nicole S.;
Paulick, Angela M.;
Perez-Carrillo, Gloria Guzman;
Liang Wang;
Hornbeck, Russ C.;
Goyal, Manu;
Vlassenko, Andrei;
Schwarz, Sally;
Nickels, Michael L.;
Wong, Dean F.;
Zhude Tu;
McConathy, Jonathan E.;
Morris, John C.;
Benzinger, Tammie L. S.;
Gordon, Brian A.

Publication type:

Article

Lesion Quantification Accuracy of Digital 90Y PET Imaging in the Context of Dosimetry in Systemic Fibroblast Activation Protein Inhibitor Radionuclide Therapy.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 2, p. 329, doi. 10.2967/jnumed.122.264338

By:

Kersting, David;
Jentzen, Walter;
Jeromin, Daniel;
Mavroeidi, Ilektra-Antonia;
Conti, Maurizio;
Büther, Florian;
Herrmann, Ken;
Rischpler, Christoph;
Hamacher, Rainer;
Fendler, Wolfgang P.;
Seifert, Robert;
Costa, Pedro Fragoso

Publication type:

Article

Longitudinal Tau PET Using 18F-Flortaucipir: The Effect of Relative Cerebral Blood Flow on Quantitative and Semiquantitative Parameters.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 2, p. 281, doi. 10.2967/jnumed.122.263926

By:

Visser, Denise;
Tuncel, Hayel;
Ossenkoppele, Rik;
Yaqub, Maqsood;
Wolters, Emma E.;
Timmers, Tessa;
Weltings, Emma;
Coomans, Emma M.;
den Hollander, Marijke E.;
van der Flier, Wiesje M.;
van Berckel, Bart N. M.;
Golla, Sandeep S. V.

Publication type:

Article

Differential Effects of Tau Stage, Lewy Body Pathology, and Substantia Nigra Degeneration on 18F-FDG PET Patterns in Clinical Alzheimer Disease.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 2, p. 274, doi. 10.2967/jnumed.122.264213

By:

Silva-Rodríguez, Jesús;
Labrador-Espinosa, Miguel A.;
Moscoso, Alexis;
Schöll, Michael;
Mir, Pablo;
Grothe, Michel J.

Publication type:

Article

Early-Phase 18F-Florbetapir and 18F-Flutemetamol Images as Proxies of Brain Metabolism in a Memory Clinic Setting.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 2, p. 266, doi. 10.2967/jnumed.122.264256

By:

Boccalini, Cecilia;
Peretti, Débora Elisa;
Ribaldi, Federica;
Scheffler, Max;
Stampacchia, Sara;
Tomczyk, Szymon;
Rodriguez, Cristelle;
Montandon, Marie-Louise;
Haller, Sven;
Giannakopoulos, Panteleimon;
Frisoni, Giovanni B.;
Perani, Daniela;
Garibotto, Valentina

Publication type:

Article

The RSNA QIBA Profile for Amyloid PET as an Imaging Biomarker for Cerebral Amyloid Quantification.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 2, p. 294, doi. 10.2967/jnumed.122.264031

By:

Smith, Anne M.;
Obuchowski, Nancy A.;
Foster, Norman L.;
Klein, Gregory;
Mozley, P. David;
Lammertsma, Adriaan A.;
Wahl, Richard L.;
Sunderland, John J.;
Vanderheyden, Jean-Luc;
Benzinger, Tammie L. S.;
Kinahan, Paul E.;
Wong, Dean F.;
Perlman, Eric S.;
Satoshi Minoshima;
Matthews, Dawn

Publication type:

Article

Prospective Phase II Trial of [68Ga]Ga-NODAGAE[c(RGDyK)]2 PET/CT Imaging of Integrin αvβ3 for Prognostication in Patients with Neuroendocrine Neoplasms.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 2, p. 252, doi. 10.2967/jnumed.122.264383

By:

Carlsen, Esben Andreas;
Loft, Mathias;
Loft, Annika;
Czyzewska, Dorota;
Andreassen, Mikkel;
Langer, Seppo W.;
Knigge, Ulrich;
Kjaer, Andreas

Publication type:

Article

Survival Outcomes in Metastatic Gastroenteropancreatic Neuroendocrine Tumor Patients Receiving Concomitant 225Ac-DOTATATE-Targeted α-Therapy and Capecitabine: A Real-World-Scenario Management-Based Long-Term Outcome Study.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 2, p. 211, doi. 10.2967/jnumed.122.264043

By:

Ballal, Sanjana;
Yadav, Madhav P.;
Tripathi, Madhavi;
Sahoo, Ranjit Kumar;
Bal, Chandrasekhar

Publication type:

Article

Static and Dynamic 68Ga-FAPI PET/CT for the Detection of Malignant Transformation of Intraductal Papillary Mucinous Neoplasia of the Pancreas.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 2, p. 244, doi. 10.2967/jnumed.122.264361

By:

Lang, Matthias;
Spektor, Anna-Maria;
Hielscher, Thomas;
Hoppner, Jorge;
Glatting, Frederik M.;
Bicu, Felix;
Hackert, Thilo;
Heger, Ulrike;
Pausch, Thomas;
Gutjahr, Ewgenija;
Rathke, Hendrik;
Giesel, Frederik L.;
Kratochwil, Clemens;
Tjaden, Christine;
Haberkorn, Uwe;
Röhrich, Manuel

Publication type:

Article

68Ga-DOTATATE Prepared from Cyclotron-Produced 68Ga: An Integrated Solution from Cyclotron Vault to Safety Assessment and Diagnostic Efficacy in Neuroendocrine Cancer Patients.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 2, p. 232, doi. 10.2967/jnumed.121.263768

By:

Tremblay, Sébastien;
Beaudoin, Jean-François;
Benesty, Ophélie Bélissant;
Ait-Mohand, Samia;
Dumulon-Perreault, Véronique;
Rousseau, Étienne;
Turcotte, Éric E.;
Guérin, Brigitte

Publication type:

Article

Whole-Body PET Imaging: A Catalyst for Whole-Person Research?

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 2, p. 197, doi. 10.2967/jnumed.122.264555

By:

Sundar, Lalith Kumar Shiyam;
Hacker, Marcus;
Beyer, Thomas

Publication type:

Article

Eligibility for 177Lu-PSMA Therapy Depends on the Choice of Companion Diagnostic Tracer: A Comparison of 68Ga-PSMA-11 and 99mTc-MIP-1404 in Metastatic Castration-Resistant Prostate Cancer.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 2, p. 227, doi. 10.2967/jnumed.122.264296

By:

Cook, Gary J. R.;
Wai-Lup Wong;
Sanghera, Bal;
Mangar, Stephen;
Challapalli, Amarnath;
Bahl, Amit;
Bassett, Paul;
Leaning, Darren;
Schmidkonz, Christian

Publication type:

Article

The Future of Targeted α-Therapy Is Bright, but Rigorous Studies Are Necessary to Advance the Field.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 2, p. 219, doi. 10.2967/jnumed.122.264805

By:

Strosberg, Jonathan;
Herrmann, Ken;
Bodei, Lisa

Publication type:

Article

Application of the Lugano Classification for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The PRoLoG Consensus Initiative (Part 2--Technical).

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 2, p. 239, doi. 10.2967/jnumed.122.264124

By:

Ricard, Fabien;
Barrington, Sally;
Korn, Ron;
Brueggenwerth, Guenther;
Trotman, Judith;
Cheson, Bruce;
Salles, Gilles;
Schwartz, Larry;
Goldmacher, Greg;
Jarecha, Rudresh;
Narang, Jayant;
Broussais, Florence;
Galette, Paul;
Min Liu;
Bajpai, Surabhi;
Perlman, Eric;
Gillis, Julie;
Smalberg, Ira;
Terve, Pierre;
Zahlmann, Gudrun

Publication type:

Article

SNMMI Procedure Standard/EANM Practice Guideline for SSTR PET: Imaging Neuroendocrine Tumors.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 2, p. 204, doi. 10.2967/jnumed.122.264860

By:

Hope, Thomas A.;
Allen-Auerbach, Martin;
Bodei, Lisa;
Calais, Jeremie;
Dahlbom, Magnus;
Dunnwald, Lisa K.;
Graham, Michael M.;
Jacene, Heather A.;
Heath, Courtney Lawhn;
Mittra, Erik S.;
Wright, Chadwick L.;
Fendler, Wolfgang P.;
Herrmann, Ken;
Taïeb, David;
Kjaer, Andreas

Publication type:

Article

Scientific Fraud, Publication Bias, and Honorary Authorship in Nuclear Medicine.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 2, p. 200, doi. 10.2967/jnumed.122.264679

By:

Kwee, Thomas C.;
Almaghrabi, Maan T.;
Kwee, Robert M.

Publication type:

Article

Evaluation of 177Lu-PSMA-617 SPECT/CT Quantitation as a Response Biomarker Within a Prospective 177Lu-PSMA-617 and NOX66 Combination Trial (LuPIN).

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 2, p. 221, doi. 10.2967/jnumed.122.264398

By:

Pathmanandavel, Sarennya;
Crumbaker, Megan;
Bao Ho;
Yam, Andrew O.;
Wilson, Peter;
Niman, Remy;
Ayers, Maria;
Sharma, Shikha;
Hickey, Adam;
Eu, Peter;
Stockler, Martin;
Martin, Andrew J.;
Joshua, Anthony M.;
Nguyen, Andrew;
Emmett, Louise

Publication type:

Article

Advancing Clinical Trial Innovation in Pancreatic Cancer: A Conversation Between Diane Simeone, Ken Herrmann, and Johannes Czernin.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 2, p. 185, doi. 10.2967/jnumed.123.265432

By:

Simeone, Diane M.;
Herrmann, Ken;
Czernin, Johannes

Publication type:

Article

Works matching IS 01615505 AND DT 2023 AND VI 64 AND IP 2

Michel Meignan, MD, PhD, 1947-2022.

Richard C. Reba, MD, 1932-2022.

Nuclear Medicine: The Essentials.

Dosimetry in Radiopharmaceutical Therapy.

Reply: Dosimetry in Radiopharmaceutical Therapy.

Precision of Myocardial Blood Flow and Flow Reserve Measurement During CZT SPECT Perfusion Imaging Processing: Intra- and Interobserver Variability.

First-in-Humans PET/MRI of In Vivo GD2 Expression in Osteosarcoma.

First-in-Humans Evaluation of Safety and Dosimetry of <sup>64</sup>Cu-LLP2A for PET Imaging.

Fetal Dose from PET and CT in Pregnant Patients.

Clinical Decision Support for Axillary Lymph Node Staging in Newly Diagnosed Breast Cancer Patients Based on <sup>18</sup>F-FDG PET/MRI and Machine Learning.

Investigating Tau and Amyloid Tracer Skull Binding in Studies of Alzheimer Disease.

Lesion Quantification Accuracy of Digital <sup>90</sup>Y PET Imaging in the Context of Dosimetry in Systemic Fibroblast Activation Protein Inhibitor Radionuclide Therapy.

Longitudinal Tau PET Using <sup>18</sup>F-Flortaucipir: The Effect of Relative Cerebral Blood Flow on Quantitative and Semiquantitative Parameters.

Differential Effects of Tau Stage, Lewy Body Pathology, and Substantia Nigra Degeneration on <sup>18</sup>F-FDG PET Patterns in Clinical Alzheimer Disease.

Early-Phase <sup>18</sup>F-Florbetapir and <sup>18</sup>F-Flutemetamol Images as Proxies of Brain Metabolism in a Memory Clinic Setting.

The RSNA QIBA Profile for Amyloid PET as an Imaging Biomarker for Cerebral Amyloid Quantification.

Prospective Phase II Trial of [<sup>68</sup>Ga]Ga-NODAGAE[c(RGDyK)]<sub>2</sub> PET/CT Imaging of Integrin α<sub>v</sub>β<sub>3</sub> for Prognostication in Patients with Neuroendocrine Neoplasms.

Survival Outcomes in Metastatic Gastroenteropancreatic Neuroendocrine Tumor Patients Receiving Concomitant <sup>225</sup>Ac-DOTATATE-Targeted α-Therapy and Capecitabine: A Real-World-Scenario Management-Based Long-Term Outcome Study.

Static and Dynamic <sup>68</sup>Ga-FAPI PET/CT for the Detection of Malignant Transformation of Intraductal Papillary Mucinous Neoplasia of the Pancreas.

<sup>68</sup>Ga-DOTATATE Prepared from Cyclotron-Produced <sup>68</sup>Ga: An Integrated Solution from Cyclotron Vault to Safety Assessment and Diagnostic Efficacy in Neuroendocrine Cancer Patients.

Whole-Body PET Imaging: A Catalyst for Whole-Person Research?

Eligibility for <sup>177</sup>Lu-PSMA Therapy Depends on the Choice of Companion Diagnostic Tracer: A Comparison of <sup>68</sup>Ga-PSMA-11 and <sup>99</sup>mTc-MIP-1404 in Metastatic Castration-Resistant Prostate Cancer.

The Future of Targeted α-Therapy Is Bright, but Rigorous Studies Are Necessary to Advance the Field.

Application of the Lugano Classification for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The PRoLoG Consensus Initiative (Part 2--Technical).

SNMMI Procedure Standard/EANM Practice Guideline for SSTR PET: Imaging Neuroendocrine Tumors.

Scientific Fraud, Publication Bias, and Honorary Authorship in Nuclear Medicine.

Evaluation of <sup>177</sup>Lu-PSMA-617 SPECT/CT Quantitation as a Response Biomarker Within a Prospective <sup>177</sup>Lu-PSMA-617 and NOX66 Combination Trial (LuPIN).

Advancing Clinical Trial Innovation in Pancreatic Cancer: A Conversation Between Diane Simeone, Ken Herrmann, and Johannes Czernin.